Nektar Therapeutics (NASDAQ:NKTR)

60.87
Delayed Data
As of 4:00pm ET
 +1.87 / +3.17%
Today’s Change
22.02
Today|||52-Week Range
111.36
+1.93%
Year-to-Date
No recent news for Nektar Therapeutics.

Today’s Trading

Previous close59.00
Today’s open58.41
Day’s range58.30 - 62.70
Volume2,979,268
Average volume (3 months)3,581,546
Market cap$10.2B
Data as of 4:00pm ET, 09/24/2018

Growth & Valuation

Earnings growth (last year)+43.64%
Earnings growth (this year)+711.87%
Earnings growth (next 5 years)-7.38%
Revenue growth (last year)+86.00%
P/E ratio12.0
Price/Sales30.27
Price/Book107.16

Competitors

 Today’s
change
Today’s
% change
NBIXNeurocrine Bioscienc...+1.43+1.20%
EXASExact Sciences Corp+2.46+3.22%
TLRYTilray Inc-23.50-19.11%
BLUEbluebird bio Inc-0.90-0.64%
Data as of 4:00pm ET, 09/24/2018

Financials

Next reporting dateNovember 8, 2018
EPS forecast (this quarter)-$0.59
Annual revenue (last year)$307.7M
Annual profit (last year)-$96.7M
Net profit margin-31.42%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Howard W. Robin
Chief Operating Officer &
Senior Vice President
John Nicholson
Corporate headquarters
San Francisco, California

Forecasts